LJHT
Laurie J. Hall Trustee Portfolio holdings
AUM
$302M
This Quarter Return
-5.15%
1 Year Return
+17.68%
3 Year Return
+82.52%
5 Year Return
+131.39%
10 Year Return
–
AUM
$203M
AUM Growth
+$203M
(-5.1%)
Cap. Flow
+$6.66M
Cap. Flow
% of AUM
3.28%
Top 10 Holdings %
Top 10 Hldgs %
34.78%
Holding
328
New
7
Increased
28
Reduced
121
Closed
7
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
$4.23M |
| 2 |
Unilever
UL
|
$1.66M |
| 3 |
IBM
IBM
|
$1.44M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$770K |
| 5 |
Vanguard Total Stock Market ETF
VTI
|
$678K |
Top Sells
| 1 |
PayPal
PYPL
|
$1.2M |
| 2 |
Medtronic
MDT
|
$1.18M |
| 3 |
Nutrien
NTR
|
$211K |
| 4 |
CDK
CDK Global, Inc.
CDK
|
$207K |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
$108K |
Sector Composition
| 1 | Healthcare | 27.28% |
| 2 | Technology | 24.66% |
| 3 | Industrials | 13.23% |
| 4 | Consumer Staples | 9.47% |
| 5 | Communication Services | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FARO
276
DELISTED
Faro Technologies
FARO
| $5K | ﹤0.01% |
190
-95
| -33% | -$2.5K |
|
277
IAC Inc
IAC
$2.93B
| $5K | ﹤0.01% |
95
-50
| -34% | -$2.63K |
|
278
Prothena Corp
PRTA
$445M
| $5K | ﹤0.01% |
80
-30
| -27% | -$1.88K |
|
279
PTC Therapeutics
PTCT
$4.16B
| $5K | ﹤0.01% |
105
-40
| -28% | -$1.91K |
|
280
Ultra Clean Holdings
UCTT
$1.08B
| $5K | ﹤0.01% |
210
-90
| -30% | -$2.14K |
|
|
ITCI
281
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $5K | ﹤0.01% |
115
-55
| -32% | -$2.39K |
|
|
EGIO
282
DELISTED
Edgio, Inc. Common Stock
EGIO
| $5K | ﹤0.01% |
1,925
+595
| +45% | +$1.55K |
|
283
Cars.com
CARS
$783M
| $4K | ﹤0.01% |
316
| – | – |
|
284
Match Group
MTCH
$8.9B
| $4K | ﹤0.01% |
81
-45
| -36% | -$2.22K |
|
285
Nokia
NOK
$22.8B
| $4K | ﹤0.01% |
1,000
| – | – |
|
|
SAGE
286
DELISTED
Sage Therapeutics
SAGE
| $4K | ﹤0.01% |
90
-40
| -31% | -$1.78K |
|
|
TVRD
287
Tvardi Therapeutics, Inc. Common Stock
TVRD
$277M
| $4K | ﹤0.01% |
390
-190
| -33% | -$1.95K |
|
288
Carnival Corp
CCL
$42.2B
| $3K | ﹤0.01% |
400
| – | – |
|
289
Cerence
CRNC
$425M
| $3K | ﹤0.01% |
190
-90
| -32% | -$1.42K |
|
290
Diamondback Energy
FANG
$43.4B
| $3K | ﹤0.01% |
26
-15
| -37% | -$1.73K |
|
291
Helmerich & Payne
HP
$2.11B
| $3K | ﹤0.01% |
85
-45
| -35% | -$1.59K |
|
292
Lexicon Pharmaceuticals
LXRX
$407M
| $3K | ﹤0.01% |
1,140
-510
| -31% | -$1.34K |
|
293
Cloudflare
NET
$72.5B
| $3K | ﹤0.01% |
50
| – | – |
|
|
IMGN
294
DELISTED
Immunogen Inc
IMGN
| $3K | ﹤0.01% |
675
-305
| -31% | -$1.36K |
|
|
AMRS
295
DELISTED
Amyris Inc.
AMRS
| $3K | ﹤0.01% |
1,095
-495
| -31% | -$1.36K |
|
296
Ultragenyx Pharmaceutical
RARE
$3.09B
| $2K | ﹤0.01% |
60
-30
| -33% | -$1K |
|
297
E.W. Scripps
SSP
$254M
| $2K | ﹤0.01% |
210
-90
| -30% | -$857 |
|
298
UNIFI
UFI
$80.6M
| $2K | ﹤0.01% |
205
-105
| -34% | -$1.02K |
|
299
Ventas
VTR
$30.9B
| $2K | ﹤0.01% |
50
| – | – |
|
|
ICPT
300
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2K | ﹤0.01% |
130
+40
| +44% | +$615 |
|